Neuronetics, inc. (STIM)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16
Cash Flows from Operating Activities:
Net loss

-29,044

-24,097

-16,059

-11,234

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

1,065

882

596

673

Share-based compensation

3,434

1,743

496

161

Non-cash interest expense

753

839

722

391

Change in fair value of convertible preferred stock warrant liability

-

1,396

-271

108

Cost of rental units purchased by customers

223

229

216

15

Changes in certain assets and liabilities:
Accounts receivable, net

950

1,353

690

123

Inventory

306

435

1,068

646

Net investments in sales-type leases

2,610

-

-

-

Prepaid commission expense

4,468

-

-

-

Prepaid expenses and other assets

565

237

175

156

Accounts payable

299

606

788

734

Accrued expenses

1,549

-52

1,391

1,201

Deferred revenue

138

-49

2,915

-

Deferred revenue

-

-

-

363

Deferred rent

-

63

5

28

Net Cash Used in Operating Activities

-30,482

-20,591

-11,144

-8,541

Cash Flows from Investing Activities:
Purchases of property and equipment and capitalized software

813

1,011

594

324

Net Cash Used in Investing Activities

-813

-1,011

-594

-324

Cash Flows from Financing Activities:
Proceeds from issuance of Series G convertible preferred stock, net

-

-

14,825

-

Borrowings under credit facilities

-

-

10,000

5,000

Payments of debt issuance costs

-

-

1,015

171

Proceeds from issuance of common stock in initial public offering

-

99,998

-

-

Payments of public offering costs

-

3,463

-

-

Proceeds from exercises of stock options

2,420

503

35

67

Net Cash Provided by Financing Activities

2,420

97,038

23,845

4,896

Net Decrease in Cash and Cash Equivalents

-28,875

75,436

12,107

-3,969

Supplemental disclosure of cash flow information:
Cash paid for interest

2,949

2,786

2,043

1,406

Transfer of inventory to property and equipment

37

365

296

531

Supplemental disclosure of non-cash investing and financing activities:
Purchases of property and equipment and capitalized software in accounts payable and accrued expenses

377

263

45

16

Conversion of convertible preferred stock into common stock

-

187,136

-

-

Conversion of convertible preferred stock warrants into common stock warrants

-

1,874

-

-

Deferred public offering costs included in accounts payable and accrued expenses

-

-

55

-

Allocation of proceeds from debt financing to convertible preferred stock warrant liability

-

-

290

135